PCORI Approves 45 CER Projects
This article was originally published in The Pink Sheet Daily
The Patient-Centered Outcomes Research Institute awarded 45 grants for comparative effectiveness research in its Dec. 17 announcement, which included the first drug vs. drug clinical trial for neuropathy and studies of medication adherence.
You may also be interested in...
Research involving drugs has been limited since the Patient-Centered Outcomes Research Institute began project funding, but institute Executive Director Joe Selby expects that to change as PCORI prepares to issue funding announcements for pragmatic trials.
Pharmaceutical companies are spending more to help patients adhere to their therapeutic regimens – an almost universally recognized way to improve health outcomes and pharma’s bottom line. But an unclear legal and regulatory climate and poor understanding of the adherence problems it is trying to solve means industry isn’t trumpeting what could be one of its best health care value arguments.
As themes of patient-centered outcomes and personalized medicine become more common in drug development, the concepts also are playing out in the medication adherence space, as shown in a program at Massachusetts General Hospital.